Be a part of 4^th European Pathology Congress

Our Mission:
To advance the field of pathology by promoting scientific excellence, innovation, and collaboration, enabling accurate diagnosis and personalized patient care.

Our Vision:
To serve as a leading European platform that drives the future of pathology through precision diagnostics, digital transformation, and patient-centered healthcare solutions.

1. Molecular & Precision Pathology:
Genomic, proteomic, and biomarker-driven diagnostics supporting precision medicine and personalized patient care.

2. Digital Pathology & Artificial Intelligence:
AI-assisted image analysis, computational pathology, automation, and digital workflow innovations.

3. Oncologic & Tumour Pathology:
Pathology of solid tumours, grading and staging systems, prognostic markers, and targeted therapeutic implications.

4. Breast Pathology & Translational Oncology:
Molecular classification, predictive biomarkers, and pathology-guided treatment strategies in breast diseases.

5. Gastrointestinal & Hepatobiliary Pathology:
Diseases of the GI tract and liver, including inflammatory, metabolic, and neoplastic conditions.

6. Hematopathology & Bone Marrow Disorders:
Leukaemia’s, lymphomas, myeloproliferative disorders, flow cytometry, and molecular hematopathology.

7. Renal & Uropathology:
Glomerular and tubulointerstitial diseases, transplant pathology, and emerging diagnostic techniques.

8. Head & Neck Pathology:
Neoplastic and non-neoplastic disorders, HPV-associated lesions, and diagnostic challenges.

9. Cytopathology & Liquid Biopsy:
Diagnostic cytology, minimally invasive techniques, circulating tumour markers, and molecular cytopathology.

10. Immunopathology & Tumour Microenvironment:
Immune-mediated diseases, immunohistochemistry, immune profiling, and immunotherapy biomarkers.

11. Clinical & Chemical Pathology:
Laboratory medicine, clinical correlations, quality assurance, and diagnostic standardization.

12. Histopathology & Surgical Pathology:
Morphologic diagnostics, advanced staining methods, digital histology, and case-based interpretations.

13. Forensic & Autopsy Pathology:
Medicolegal pathology, postmortem diagnostics, molecular forensics, and cause-of-death investigations.

14. Experimental & Translational Pathology:
Disease models, organoids, translational research, and bench-to-bedside applications.

The European pathology and diagnostic services market is undergoing a significant transformation, driven by advances in precision medicine, digital pathology, artificial intelligence (AI), and molecular diagnostics. Pathology plays a central role in modern healthcare, particularly in oncology, chronic disease management, and personalized treatment planning. With the rising incidence of cancer, autoimmune disorders, and metabolic diseases across Europe, the demand for accurate, timely, and technology-enabled diagnostics continues to grow.

Europe represents one of the most mature and rapidly evolving pathology markets globally, supported by strong healthcare infrastructure, academic excellence, and regulatory initiatives promoting innovation. Countries such as France, Germany, the United Kingdom, Italy, and the Nordic region are actively investing in digital pathology platforms, AI-assisted image analysis, and integrated laboratory information systems. The adoption of whole-slide imaging, telepathology, and data-driven diagnostics is accelerating both in clinical practice and research settings.

Additionally, increased emphasis on personalized and precision medicine has expanded the role of molecular pathology, biomarker discovery, and companion diagnostics. Industry stakeholders—including diagnostic companies, AI solution providers, and laboratory technology manufacturers—are aligning closely with academic and clinical institutions to translate research into routine practice.

Against this backdrop, Euro Pathology 2026 is strategically positioned to address current market needs by bringing together scientists, clinicians, policymakers, and industry leaders. The congress serves as a critical platform to exchange knowledge, showcase innovation, foster collaboration, and shape the future of pathology in Europe, reinforcing its role as a cornerstone of patient-centered healthcare.

Why Attend:

• Gain insights into the latest advances in precision and personalized pathology
• Learn from international experts and key opinion leaders
• Explore innovations in digital pathology, AI, and molecular diagnostics
• Present your research and receive global visibility
• Network with academia, clinicians, and industry professionals
• Enhance clinical practice and research impact through evidence-based discussions

Who Should Attend:

• Pathologists & Histopathologists
• Molecular & Digital Pathologists
• Laboratory Medicine Professionals
• Oncologists & Clinicians
• Researchers & Academicians
• Biomedical Scientists
• Healthcare Professionals & Industry Experts
• Students, PhD Scholars & Early-Career Pathologists